We hypothesized that individuals with homozygous EPCAM deletion will exhibit a unique “tissue-specific CMMRD” and will develop hypermutation, microsatellite instability and cancers restricted to tissues in which EPCAM is expressed. This evidence concerns the gene EPCAM and cancer.